Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2007

View Archived Issues

Novel therapeutic agents for cancer covered in recent patents

Recent Merck & Co. and Actelion patents disclose new immunomodulatory agents

New agents for substance abuse imparted in recent Auspex patent

Snapshots of clinical trial data presented at EULAR 2007

Patient enrollment complete in phase III telavancin study

Lorus initiates GTI-2040 clinical trial in acute leukemia and MDS

Alexza Pharmaceuticals seeks to expand AZ-104 indication

Methotrexate prodrug effective in experimental models of rheumatoid arthritis

SLx-2119: a potent ROCK-2 inhibitor that inhibits septic liver injury in vivo

MIF inhibition shows promise in murine models of arthritis

LEO Pharma's novel p38 MAPK inhibitor shows efficacy in animal models of arthritis and psoriasis

Successful follow-up study of QR-443 in cachexia model

Gardasil sBLA accepted for review

RAID program supports development of SR-16388 to treat advanced cancers

Inspire and FAES Farma amend oral bilastine licensing agreement

HuCAL-derived antibody to begin phase I in oncology

End of phase II meeting for Qnexa

IND filing for Src kinase inhibitor KX2-391

Date set for Advisory Committee review of Repel-CV PMA

Phase II trial planned for LCP-Tacro in prevention of organ rejection

DSMB recommendation to continue European tramiprosate phase III study

Antiviral response observed in bevirimat 250 mg cohort

Dextofisopam advances to phase IIb IBS study

Anadys Pharmaceuticals nominates ANA-598 for clinical development

FDA approves commencement of phase II iclaprim trial

E.U. approval for Soliris

Rasilez recommended for E.U. approval

Lyrica approved for fibromyalgia

E.U. approval recommended for Atriance in relapsed or refractory T-ALL, T-LBL

FDA approves sugar-free Carnitor for carnitine deficiency

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...